MarketPeel
Insider Trading Intelligence
MP

Mukund Paravasthu

NVCR
CHIEF OPERATING OFFICER · NOVOCURE LTD · CIK 0002039078
FILING MIX · LIFETIME28%/72%
BUYS
7
SELLS
18
TOTAL VALUE
$4.16M
COMPANIES
1
ACTIVE SINCE
Nov 2024
HOLDINGS NOW
72,832
AVG SELL PX
$14.56
TRADE KIND
SHOWING 25 / 25
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 20 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mukund Paravasthu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+50.00%-0.64%-0.49%-0.14%-0.18%
14d12+66.67%-2.84%-1.46%-1.38%-4.46%
30d12+83.33%+3.12%-1.52%+4.65%-5.84%
60d12+58.33%+15.30%+0.87%+14.43%+1.77%
90d12+25.00%+11.15%+2.12%+1.31%-0.03%
180d12(4 pending)+75.00%-23.32%+8.18%-31.50%-45.28%
1y12(4 pending)+100.00%-26.78%+19.42%-46.19%-44.74%
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NVCR · 72,832 shares · as of Mar 5, 2026
030,36460,72891,091121,45520252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
FLOW · 7 buys / 18 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
43,246$13.77$595.7K72,832Mar 5, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
5,377$13.31$71.5K116,078Mar 4, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
58,48866,006Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
45,112121,455Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
7,5187,518Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
408$13.49$5.5K76,343Mar 2, 2026Mar 3, 2026View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
1,555$13.66$21.2K76,751Feb 27, 2026Mar 3, 2026View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
2,133$14.35$30.6K78,306Jan 11, 2026Jan 12, 2026View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
2,949$12.23$36.1K80,439Nov 4, 2025Nov 4, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
168$12.81$2.2K83,388Nov 1, 2025Nov 4, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
592$17.91$10.6K83,556May 3, 2025May 5, 2025View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
54,975$18.19$1000.0K84,148Mar 4, 2025Mar 6, 2025View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
81,499$18.19$1.48M81,499Mar 4, 2025Mar 6, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
250$18.54$4.6K29,173Mar 3, 2025Mar 4, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
368$18.28$6.7K29,423Feb 28, 2025Mar 3, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
368$18.28$6.7K29,423Feb 28, 2025Mar 3, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
1,379$19.92$27.5K30,058Feb 27, 2025Mar 3, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
267$20.55$5.5K29,791Feb 27, 2025Mar 3, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
267$20.55$5.5K29,791Feb 27, 2025Mar 3, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
1,379$19.92$27.5K30,058Feb 27, 2025Mar 3, 2025View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
2,160$26.81$57.9K31,437Jan 11, 2025Jan 15, 2025View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
30,13833,597Nov 4, 2024Nov 6, 2024View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
45,620$16.59$756.8K45,620Nov 4, 2024Nov 6, 2024View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
44$16.69$7343,459Nov 2, 2024Nov 6, 2024View →
NVCR
NOVOCURE LTD
SALE
Chief Operating Officer
160$15.88$2.5K3,503Nov 1, 2024Nov 4, 2024View →
Other insiders · NVCR
Loading peer insiders…
About this filer
CIK 0002039078
ROLE
Chief Operating Officer
PRIMARY
NVCR
COMPANIES
1
ACTIVE SINCE
Nov 2024
MARKETPEEL · /INSIDER/0002039078DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback